4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial-Reference-Cited by-同舟云学术

4-Hexyl-1,3-phenylenediol, a nuclear factor-κB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial

Published:2015-06-11 Issue:1 Volume:173 Page:218-226
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Kaur S.¹,Kizoulis M.¹,Fantasia J.¹,Oddos T.²,Bigot N.³,Galera P.³,Tucker-Samaras S.¹,Leyden J.J.⁴,Southall M.D.¹

Affiliation:

1. Johnson and Johnson Skin Research Center; CPPW; A Division of Johnson and Johnson Consumer Companies, Inc.; 199 Grandview Road, Skillman NJ 08558 U.S.A

2. Johnson and Johnson Skin Research Center; CPPW; A Division of Johnson and Johnson Consumer Companies, Inc.; Val de Reuil France

3. Laboratoire Microenvironnement Cellulaire et Pathologies; (MILPAT) EA 4652; SFR ICORE 146 UCBN; UFR de Médecine; CHU Niveau 3 Avenue de la Côte de Nacre 14032 CAEN Cedex France

4. University of Pennsylvania Medical School; 415 Curie Blvd Philadelphia PA 19104 U.S.A

Funder

Johnson & Johnson Consumer Companies, Inc. Skillman, New Jersey, U.S.A.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.13747/fullpdf

Reference38 articles.

1. Photoaging of the skin from phenotype to mechanisms;Scharffetter-Kochanek;Exp Gerontol,2000

2. Structural alterations in exposed and unexposed aged skin;Lavker;J Invest Dermatol,1979